NYSE:IFF - International Flavors & Fragrances Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $145.49
  • Forecasted Upside: 2.59 %
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$141.82
▼ -1.1 (-0.77%)
1 month | 3 months | 12 months
Get New International Flavors & Fragrances Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IFF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IFF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$145.49
▲ +2.59% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for International Flavors & Fragrances in the last 3 months. The average price target is $145.49, with a high forecast of $160.00 and a low forecast of $111.00. The average price target represents a 2.59% upside from the last price of $141.82.
Buy
The current consensus among 15 investment analysts is to buy stock in International Flavors & Fragrances. This rating has held steady since November 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 2 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/20/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/21/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/19/2021Morgan StanleyReiterated RatingOverweight$160.00N/A
i
4/12/2021Morgan StanleyInitiated CoverageOverweight$160.00Low
i
3/31/2021Berenberg BankUpgradeHold ➝ Buy$139.00 ➝ $160.00Low
i
3/26/2021JPMorgan Chase & Co.Boost Price TargetOverweight$141.00 ➝ $155.00Low
i
3/25/2021Berenberg BankUpgradeHold ➝ Buy$139.00 ➝ $160.00High
i
3/17/2021Jefferies Financial GroupInitiated CoverageBuy$155.00Low
i
3/11/2021Jefferies Financial GroupInitiated CoverageBuy$155.00Low
i
2/12/2021JPMorgan Chase & Co.Boost Price TargetOverweight$138.00 ➝ $141.00Low
i
1/12/2021Exane BNP ParibasUpgradeUnderperform ➝ NeutralLow
i
1/12/2021Societe GeneraleUpgradeHold ➝ Buy$122.00 ➝ $145.00High
i
1/12/2021BNP ParibasUpgradeUnderperform ➝ Neutral$122.00High
i
11/12/2020Societe GeneraleUpgradeSell ➝ Hold$122.00Low
i
10/9/2020Bank of AmericaInitiated CoverageBuy$155.00High
i
8/26/2020Robert W. BairdInitiated CoverageOutperform$150.00Low
i
8/12/2020Stifel NicolausLower Price TargetHold$135.00 ➝ $132.00Medium
i
7/9/2020StephensInitiated CoverageOverweight$150.00Medium
i
6/22/2020Exane BNP ParibasDowngradeNeutral ➝ Underperform$111.00Low
i
6/22/2020BNP ParibasDowngradeNeutral ➝ Underperform$111.00Low
i
6/3/2020Wells Fargo & CompanyReiterated RatingBuyMedium
i
Rating by Michael Sison at Wells Fargo & Company
5/13/2020CitigroupBoost Price TargetNeutral$113.00 ➝ $133.40High
i
Rating by PJ Juvekar at Citigroup Inc.
5/13/2020CfraBoost Price TargetBuy$143.00 ➝ $148.00High
i
5/12/2020UBS GroupBoost Price TargetBuy$154.00 ➝ $156.00Medium
i
4/29/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$141.00 ➝ $150.00Medium
i
Rating by Michael Sison at Wells Fargo & Company
4/9/2020CitigroupLower Price TargetNeutral$114.00 ➝ $113.00High
i
Rating by PJ Juvekar at Citigroup Inc.
4/8/2020UBS GroupLower Price TargetBuy$163.00 ➝ $154.00High
i
4/6/2020Exane BNP ParibasUpgradeUnderperform ➝ Neutral$110.00Medium
i
4/6/2020BNP ParibasUpgradeUnderperform ➝ Neutral$98.90 ➝ $110.00High
i
2/19/2020BarclaysReiterated RatingSell$119.00Low
i
2/14/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$135.00 ➝ $141.00Low
i
Rating by Michael Sison at Wells Fargo & Company
12/16/2019CitigroupDowngradeBuy ➝ NeutralLow
i
Rating by PJ Juvekar at Citigroup Inc.
12/16/2019Societe GeneraleDowngradeBuy ➝ Sell$122.00Low
i
12/16/2019Stifel NicolausLower Price TargetHold$135.00 ➝ $130.00High
i
Rating by Mark Astrachan at Stifel Nicolaus
12/12/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$145.00 ➝ $151.00Low
i
12/6/2019JPMorgan Chase & Co.Boost Price TargetOverweight$140.00 ➝ $150.00Low
i
11/22/2019CitigroupUpgradeNeutral ➝ Buy$137.00 ➝ $155.00Medium
i
Rating by PJ Juvekar at Citigroup Inc.
11/7/2019BarclaysReiterated RatingSellLow
i
11/6/2019JPMorgan Chase & Co.Boost Price Target$125.00 ➝ $140.00Low
i
11/6/2019Wells Fargo & CompanyBoost Price TargetMarket Perform$125.00 ➝ $135.00Low
i
Rating by Michael Sison at Wells Fargo & Company
10/15/2019Wells Fargo & CompanyInitiated CoverageMarket Perform$125.00Low
i
10/9/2019CitigroupLower Price TargetNeutral$129.00 ➝ $126.00Low
i
10/2/2019UBS GroupLower Price TargetBuy$171.00 ➝ $163.00High
i
9/9/2019Societe GeneraleInitiated CoverageBuy$140.00High
i
8/8/2019KeyCorpLower Price TargetOverweight$160.00 ➝ $150.00Low
i
8/8/2019Berenberg BankDowngradeBuy ➝ Hold$155.00 ➝ $133.00Low
i
8/7/2019Stifel NicolausSet Price TargetHold$120.00Low
i
Rating by Mark Astrachan at Stifel Nicolaus
8/7/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$127.00 ➝ $125.00High
i
6/21/2019Exane BNP ParibasDowngradeUnderperformMedium
i
6/21/2019BNP ParibasDowngradeNeutral ➝ UnderperformMedium
i
6/7/2019KeyCorpBoost Price TargetOverweight$143.00 ➝ $160.00Medium
i
5/7/2019UBS GroupBoost Price TargetBuy ➝ Buy$168.00 ➝ $172.00High
i
3/21/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$137.00 ➝ $151.00High
i
2/25/2019KeyCorpLower Price TargetOverweight ➝ Overweight$160.00 ➝ $143.00Low
i
2/21/2019Seaport Global SecuritiesInitiated CoverageNeutral ➝ NeutralLow
i
Rating by B. Hundley at Seaport Global Securities
2/21/2019CitigroupLower Price TargetNeutral ➝ Neutral$146.00 ➝ $139.00Low
i
Rating by Daniel Jester at Citigroup Inc.
2/18/2019BarclaysReiterated RatingSellHigh
i
11/16/2018Raymond JamesDowngradeMarket Perform ➝ Underperform$135.00Low
i
Rating by Patrick Lambert at Raymond James
11/16/2018CitigroupInitiated CoverageNeutral ➝ Neutral$152.00Low
i
Rating by Daniel Jester at Citigroup Inc.
10/16/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$126.00 ➝ $154.00High
i
8/9/2018Stifel NicolausReiterated RatingHold ➝ Hold$135.00 ➝ $139.00Low
i
6/11/2018Stifel NicolausLower Price TargetHold ➝ Hold$146.00 ➝ $135.00Low
i
6/8/2018ArgusDowngradeBuy ➝ HoldLow
i
5/14/2018JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightLow
i
5/10/2018Sanford C. BernsteinSet Price TargetBuy$160.00 ➝ $155.00Medium
i
5/8/2018Stifel NicolausLower Price TargetHold ➝ Hold$147.00Medium
i
5/8/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$135.00 ➝ $124.00Low
i
5/8/2018JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$130.00Low
i
3/16/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$140.00 ➝ $130.00Low
i
3/15/2018BarclaysSet Price TargetSell$131.00Low
i
Rating by Lauren Lieberman at Barclays PLC
2/16/2018KeyCorpLower Price TargetOverweight ➝ Overweight$162.00 ➝ $156.00Low
i
2/15/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$150.00 ➝ $147.00Medium
i
1/17/2018Evercore ISIUpgradeIn-Line ➝ OutperformHigh
i
11/10/2017Berenberg BankReiterated RatingBuy$160.00N/A
i
11/7/2017UBS GroupReiterated RatingBuy$151.00 ➝ $166.00N/A
i
10/16/2017KeyCorpBoost Price TargetOverweight$148.00 ➝ $156.00N/A
i
10/4/2017KeyCorpReiterated RatingBuy$148.00Low
i
8/24/2017KeyCorpReiterated RatingBuy$148.00Low
i
8/11/2017BarclaysReiterated RatingSell$123.00Low
i
Rating by Lauren Lieberman at Barclays PLC
8/10/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$135.00 ➝ $139.00Low
i
7/21/2017Stifel NicolausReiterated RatingHold$136.00Low
i
7/7/2017Raymond JamesInitiated CoverageMarket PerformLow
i
6/16/2017Stifel NicolausReiterated RatingHold$129.00 ➝ $136.00Medium
i
5/12/2017BarclaysReiterated RatingSellLow
i
Rating by Lauren Lieberman at Barclays PLC
5/10/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$125.00 ➝ $132.00Low
i
5/9/2017Vertical ResearchDowngradeBuy ➝ HoldLow
i
3/27/2017Stifel NicolausBoost Price TargetHold$123.00 ➝ $127.00Low
i
Rating by Mark Astrachan at Stifel Nicolaus
2/23/2017UBS GroupUpgradeNeutral ➝ Buy$129.00 ➝ $138.00N/A
i
2/18/2017BarclaysSet Price TargetSell$112.00N/A
i
Rating by Lauren Lieberman at Barclays PLC
2/16/2017Consumer EdgeDowngradeOutperform ➝ NeutralN/A
i
2/13/2017Evercore ISIInitiated CoverageHold$125.00N/A
i
1/9/2017BarclaysDowngradeEqual Weight ➝ Underweight$133.00 ➝ $103.00N/A
i
1/6/2017Exane BNP ParibasDowngradeOutperform ➝ Neutral$132.00N/A
i
1/6/2017BNP ParibasReiterated RatingOutperform ➝ Neutral$160.00 ➝ $132.00N/A
i
11/21/2016The Goldman Sachs GroupInitiated CoverageNeutral$121.50N/A
i
11/10/2016UBS GroupReiterated RatingNeutral$132.00 ➝ $129.00N/A
i
11/8/2016Stifel NicolausLower Price TargetHold$140.00 ➝ $121.00N/A
i
10/13/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$137.00N/A
i
Rating by Bill Schmitz at Deutsche Bank Aktiengesellschaft
9/26/2016Berenberg BankReiterated RatingBuy$163.40N/A
i
9/19/2016Sanford C. BernsteinInitiated CoverageOutperform$160.00N/A
i
8/16/2016ArgusBoost Price TargetBuy$146.00 ➝ $156.00N/A
i
8/14/2016JPMorgan Chase & Co.Reiterated RatingBuy$153.00N/A
i
8/10/2016GabelliDowngradeBuy ➝ HoldN/A
i
Rating by S. Donnelly at Gabelli
8/9/2016UBS GroupBoost Price TargetNeutral$118.00 ➝ $132.00N/A
i
7/24/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$124.00 ➝ $130.00N/A
i
Rating by Bill Schmitz at Deutsche Bank Aktiengesellschaft
7/20/2016Berenberg BankInitiated CoverageBuy$163.40N/A
i
5/11/2016Deutsche Bank AktiengesellschaftBoost Price TargetHold$115.00 ➝ $124.00N/A
i
Rating by Bill Schmitz at Deutsche Bank Aktiengesellschaft
(Data available from 4/21/2016 forward)
International Flavors & Fragrances logo
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers flavor compounds; savory solutions, such as marinades or powder blends of flavors, natural colors, seasonings, functional ingredients, and natural anti-oxidants; and inclusions. It also provides nutrition and specialty ingredients primarily consist of natural health ingredients, natural food protection products, and natural colors and flavor ingredients. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and alginates-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Read More

Today's Range

Now: $141.82
$141.11
$143.04

50 Day Range

MA: $137.99
$130.89
$142.92

52 Week Range

Now: $141.82
$99.54
$143.18

Volume

885,100 shs

Average Volume

5,157,942 shs

Market Capitalization

$35.29 billion

P/E Ratio

42.46

Dividend Yield

2.16%

Beta

0.97

Frequently Asked Questions

What sell-side analysts currently cover shares of International Flavors & Fragrances?

The following Wall Street sell-side analysts have issued reports on International Flavors & Fragrances in the last year: Bank of America Co., Berenberg Bank, BNP Paribas, Cfra, Citigroup Inc., Exane BNP Paribas, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, Societe Generale, Stephens, Stifel Nicolaus, UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for IFF.

What is the current price target for International Flavors & Fragrances?

15 Wall Street analysts have set twelve-month price targets for International Flavors & Fragrances in the last year. Their average twelve-month price target is $145.49, suggesting a possible upside of 2.6%. Morgan Stanley has the highest price target set, predicting IFF will reach $160.00 in the next twelve months. Exane BNP Paribas has the lowest price target set, forecasting a price of $111.00 for International Flavors & Fragrances in the next year.
View the latest price targets for IFF.

What is the current consensus analyst rating for International Flavors & Fragrances?

International Flavors & Fragrances currently has 4 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IFF will outperform the market and that investors should add to their positions of International Flavors & Fragrances.
View the latest ratings for IFF.

What other companies compete with International Flavors & Fragrances?

How do I contact International Flavors & Fragrances' investor relations team?

International Flavors & Fragrances' physical mailing address is 521 W 57TH ST, NEW YORK NY, 10019. The specialty chemicals company's listed phone number is 212-765-5500 and its investor relations email address is [email protected] The official website for International Flavors & Fragrances is www.iff.com.